Modeling indoxyl sulfate transport in a bioartificial kidney: Two-step binding kinetics or lumped parameters model for uremic toxin clearance?

Toxin removal by the kidney is deficient in a patient suffering from end-stage kidney disease (ESKD), and current dialysis therapies are insufficient in subsidizing this loss. A bioartificial kidney (BAK) aspires to offer ESKD patients a more effective alternative to dialysis. Mathematical models are necessary to support further developments and improve designs for the BAK before clinical trials. The BAK differentiates itself from dialysis by incorporating a living proximal tubule cell monolayer to account for the active transport of protein-bound uremic toxins, namely indoxyl sulfate (IS) in this study. Optimizing such a device is far from trivial due to the non-intuitive spatiotemporal dynamics of the IS removal process. This study used mathematical models to compare two types of active transport kinetics. i.e., two-step binding and lumped parameter. The modeling results indicated that the transporter density is the most influential parameter for the IS clearance. Moreover, a uniform distribution of transporters increases the IS clearance, highlighting the need for a high-quality, functional proximal tubule monolayer in the BAK. In summary, this study contributed to an improved understanding of IS transport in the BAK, which can be used along with laboratory experiments to develop promising renal replacement therapies in the future.

[1]  D. Stamatialis,et al.  New insights into the effects of biomaterial chemistry and topography on the morphology of kidney epithelial cells , 2018, Journal of tissue engineering and regenerative medicine.

[2]  C. Ronco,et al.  Uremic Toxins and their Relation to Dialysis Efficacy , 2019, Blood Purification.

[3]  Raymond Vanholder,et al.  Normal and pathologic concentrations of uremic toxins. , 2012, Journal of the American Society of Nephrology : JASN.

[4]  C. Mummery,et al.  Organs-on-chips: into the next decade , 2020, Nature Reviews Drug Discovery.

[5]  J. Berns Improving Care of Patients With CKD: The 2015 National Kidney Foundation Presidential Address. , 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[6]  Josep Samitier,et al.  Mimicking the Kidney: A Key Role in Organ-on-Chip Development , 2016, Micromachines.

[7]  T. Abe,et al.  The kidney and uremic toxin removal: glomerulus or tubule? , 2014, Seminars in nephrology.

[8]  Aleksandra Galetin,et al.  Quantitative translation of microfluidic transporter in vitro data to in vivo reveals impaired albumin-facilitated indoxyl sulfate secretion in chronic kidney disease. , 2019, Molecular pharmaceutics.

[9]  K. Mawatari,et al.  Cell sheet mechanics: How geometrical constraints induce the detachment of cell sheets from concave surfaces. , 2016, Acta biomaterialia.

[10]  J. Wetzels,et al.  Uremic Toxins Inhibit Transport by Breast Cancer Resistance Protein and Multidrug Resistance Protein 4 at Clinically Relevant Concentrations , 2011, PloS one.

[11]  K. P. Lehre,et al.  The Number of Glutamate Transporter Subtype Molecules at Glutamatergic Synapses: Chemical and Stereological Quantification in Young Adult Rat Brain , 1998, The Journal of Neuroscience.

[12]  A. Vandewalle,et al.  Cell models for studying renal physiology , 2008, Pflügers Archiv - European Journal of Physiology.

[13]  A. Weinstein A mathematical model of rat distal convoluted tubule. I. Cotransporter function in early DCT. , 2005, American journal of physiology. Renal physiology.

[14]  Christopher Probst,et al.  Integration concepts for multi-organ chips: how to maintain flexibility?! , 2017, Future science OA.